Delving into the Latest Updates on Canghuo Pingwei Granules with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Digestive System Disorders

Active Indication

Chronic superficial gastritis

Inactive Indication-

Originator Organization-

Active Organization-

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

进行苍藿平胃颗粒治疗慢性浅表性胃炎（脾胃湿热证）消化不良症状8周后患者有效性和安全性的Ⅱ期临床研究，为Ⅲ期临床研究提供依据。主要研究目的：采用安慰剂对照，评价苍藿平胃颗粒治疗慢性浅表性胃炎（脾胃湿热证）消化不良症状有效性。次要目的：通过评价两组间不良事件发生率，比较试验组与对照组安全性指标的差异。

[Translation]

A Phase II clinical study was conducted to evaluate the effectiveness and safety of Canghuo Pingwei Granules in treating dyspepsia symptoms of chronic superficial gastritis (spleen and stomach damp-heat syndrome) after 8 weeks, to provide a basis for Phase III clinical studies. Main purpose of the study: To evaluate the effectiveness of Canghuo Pingwei Granules in treating dyspepsia symptoms of chronic superficial gastritis (spleen and stomach damp-heat syndrome) by placebo control. Secondary purpose: To compare the differences in safety indicators between the experimental group and the control group by evaluating the incidence of adverse events between the two groups.

Start Date23 Jun 2020

Sponsor / Collaborator